Working… Menu
Trial record 1 of 2 for:    UV1 and ipilimumab
Previous Study | Return to List | Next Study

Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02275416
Recruitment Status : Active, not recruiting
First Posted : October 27, 2014
Last Update Posted : May 7, 2019
Oslo University Hospital
Information provided by (Responsible Party):
Ultimovacs AS

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : February 2020
Estimated Study Completion Date : February 2025